We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Click here

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,068.80
(
0.05%
)
S&P ASX All Technology
2,475.20
(
-0.55%
)
Brent Oil
92.485
(
0.0%
)
US Dollar vs AUD
1.55231
(
0.0%
)
Bitcoin
26,568.64
(
-0.03%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) News

EOLS

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
09/09/202310:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NASDAQ:EOLSEvolus Inc
29/08/202322:45Business WireEvolus to Participate in September Conferences NASDAQ:EOLSEvolus Inc
24/08/202310:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NASDAQ:EOLSEvolus Inc
24/08/202310:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securities NASDAQ:EOLSEvolus Inc
24/08/202308:53Business WireEvolus Announces Inducement Grants for New Chief Marketing Officer NASDAQ:EOLSEvolus Inc
21/08/202322:45Business WireEvolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer NASDAQ:EOLSEvolus Inc
17/08/202310:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NASDAQ:EOLSEvolus Inc
17/08/202310:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NASDAQ:EOLSEvolus Inc
16/08/202306:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NASDAQ:EOLSEvolus Inc
15/08/202306:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] NASDAQ:EOLSEvolus Inc
08/08/202322:45Business WireEvolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers NASDAQ:EOLSEvolus Inc
03/08/202307:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)] NASDAQ:EOLSEvolus Inc
03/08/202306:08Edgar (US Regulatory)Form 8-K - Current report NASDAQ:EOLSEvolus Inc
03/08/202306:05Business WireEvolus Reports Second Quarter 2023 Results and Provides Business Update NASDAQ:EOLSEvolus Inc
27/07/202322:55Edgar (US Regulatory)Form 8-K - Current report NASDAQ:EOLSEvolus Inc
27/07/202322:45Business WireEvolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue NASDAQ:EOLSEvolus Inc
26/07/202322:45Business WireEvolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference NASDAQ:EOLSEvolus Inc
19/07/202322:45Business WireEvolus to Report Second Quarter 2023 Results and Provide Business Update NASDAQ:EOLSEvolus Inc
29/06/202323:00Business WireEvolus Launches Nuceiva® (botulinum toxin type A) in Italy NASDAQ:EOLSEvolus Inc
22/06/202322:45Business WireEvolus Announces Successful Completion of Phase 2 Study Evaluating “Extra-Strength” Dose of Jeuveau ® NASDAQ:EOLSEvolus Inc
17/06/202306:55Edgar (US Regulatory)Statement of Ownership (sc 13g) NASDAQ:EOLSEvolus Inc
15/06/202306:40Edgar (US Regulatory)Current Report Filing (8-k) NASDAQ:EOLSEvolus Inc
10/06/202306:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) NASDAQ:EOLSEvolus Inc
09/06/202306:05Business WireEvolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program NASDAQ:EOLSEvolus Inc
08/06/202307:14Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a) NASDAQ:EOLSEvolus Inc
10/05/202308:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:EOLSEvolus Inc
10/05/202307:13Edgar (US Regulatory)Quarterly Report (10-q) NASDAQ:EOLSEvolus Inc
10/05/202306:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a) NASDAQ:EOLSEvolus Inc
10/05/202306:08Edgar (US Regulatory)Current Report Filing (8-k) NASDAQ:EOLSEvolus Inc
10/05/202306:01Business WireEvolus Announces Expansion into U.S. Dermal Filler Market with Evolysse™, a First-Generation Cold Technology HA by Symatese NASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS
Your Recent History
FX
EURAUD
Euro vs Au..
FX
USDAUD
US Dollar ..
ASX
WPL
Woodside
NASDAQ
AAPL
Apple
ASX
BHP
BHP Bilito..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230923 09:05:48